From innovation to access: A shared vision for the 4th UN High-level Meeting on NCDs and Mental Health
Date
11 March 2025
Time
15:00 - 18:00 EST
Hosts
IFPMA
Location
601 Lexington Avenue, 14th Floor
New York, NY 10022
Attendance
This event has now passed. To browse our upcoming events click here.
From developing innovative medicines and vaccines to driving initiatives that support equitable access, the pharmaceutical industry is a critical private sector stakeholder committed to addressing the global NCDs burden and improving health everywhere.
On 11 March, IFPMA is hosting an in-person event in New York to launch our non-communicable disease (NCDs) “Call to Action.” This is an important milestone ahead of the UN High-Level Meting on NCDs and Mental Health taking place later this year.
The global burden of NCDs – which include diabetes, cancer, cardiovascular disease, lung disease, mental health, and neurological disorders – presents a critical challenge to patients, health systems, economies, and societies worldwide, and the UN High-Level Meeting is expected to result in a Political Declaration to drive global progress to tackle this rising global health challenge.
This event will be a platform for cross-sectoral engagement among leaders from governments, the private sector, academia, and civil society to highlight actionable pathways to progress and goal-setting for NCDs and Universal Health Coverage (UHC) – through 2030 and with a vision to 2050. It will include a series of keynotes and panel discussions followed by a networking reception.
Address
601 Lexington Avenue, 14th Floor
New York, NY 10022
Register to attend
This is an in-person only event and registration is required. To book your place, click the button below and continue through to the registration page.
Program
During this opening session, IFPMA will introduce the industry’s call to action and briefly address the goals of the event. Ambassador François Jackman will offer insights and learnings from the 2024 UN High-level Meeting on AMR.
Ambassador François Jackman, Permanent Representative of Barbados to the United Nations
Melissa Gong Mitchell, Senior Managing Director, High Lantern Group
James Anderson, Executive Director, Global Health, IFPMA
The co-facilitator of the 2024 UN General Assembly High-level Meeting on NCDs and Mental Health will provide an overview of the key milestones on the road to the HLM as well as identifying key shared priorities for potential inclusion in the meeting outcome decree.
Ambassador Inga Rhonda King, Permanent Representative of St. Vincent and the Grenadines to the United Nations
This session will address effective programs and policies to ensure equitable access to NCD prevention, treatment, and care for all. Panelists will discuss the need for strengthening national health systems by integrating early screening, diagnosis, vaccination, comprehensive treatment options, and rehabilitation programs that effectively reach and address the needs of people living with NCDs and mental health conditions.
Ambassador YAMAZAKI Kazuyuki, Permanent Representative of Japan to the United Nations
MODERATOR Johanna Ralston, CEO, World Obesity Federation
Chris Bryant, host of “You have diabetes, Diabetes doesn’t have you!” Support Group of the Diabetes Foundation, Ambassador for the American Kidney Fund, Board Member for the NJ Sharing Network
Roshini George, Senior Program Officer, Non-Communicable Diseases, PATH
Jennifer Young, Vice President & Head, Global Business Policy and Public Affairs, Pfizer
This session will address the need for more efficient and effective investment in strengthening health systems. Panelists will discuss the need for concrete and actionable financing plans for NCDs and mental health to more equitably reach individuals with integrated prevention, treatment, and care.
MODERATOR Jenelle Krishnamoorthy, VP, Head of Global Public Policy and International Affairs, MSD (also known as Merck in the US)
Mike Hodin, CEO, Global Coalition on Aging
Sylvia Paola Mendoza Elguea, Coordinator, Economic, Social, Human Rights and Humanitarian Affairs, Permanent Mission of Mexico to the United Nations
James Reid, Program Officer, T1D Global Access, Helmsley Charitable Trust
This session will address policies and programs needed to foster a healthy innovation ecosystem and improve awareness and uptake of medical innovation to address the global burden of NCDs and mental health. This includes the need for essential and innovative NCD medicines, vaccines, diagnostics, and medical devices, supported by appropriate health service delivery models to ensure equitable access.
The panel will also address accountability measures and how to ensure high standards across relevant stakeholders for accurately reporting and improve delivery of care, including the impact of vaccination, early screening, diagnosis, and treatment.
MODERATOR Marijke Kremin, Policy & Advocacy Manager, NCD Alliance
Ambassador Vathayudh Vichankaiyakij, Deputy Permanent Representative of Thailand to the United Nations
Fouzia Shafique, Associate Director, Health Programmes, UNICEF
Martin Whalen, Senior Vice President Global Policy and International Government Affairs, Bristol Myers Squibb
Speakers will address the critical role of the multilateral system in advancing progress on NCDs, and the diverse stakeholders needed to advance action leading up to the High-level Meeting and beyond.
Werner Obermeyer, Director, World Health Organization (WHO) office at the UN Headquarters in New York
Vanessa Peberdy, Deputy Director, Health Progress, IFPMA